AHA/ACC/ADA issue statement on intensive glycemic control
19 December 2008
MedWire News: Three leading US diabetes and cardiovascular (CV) organizations have issued a statement in which they urge clinicians to continue to pursue a glycated hemoglobin target of less than 7.0%, alongside aggressive risk-factor control, in order to reduce the risk of microvascular complications in Type 2 diabetes. /.../
No comments:
Post a Comment